Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy

Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy

Summary: Combination therapy (lenvatinib/programmed death-1 inhibitor) is effective for treating unresectable hepatocellular carcinoma (uHCC). We reveal that responders have better overall and progression-free survival, as well as high tumor mutation burden and special somatic variants. We analyze t...

Full description

Bibliographic Details
Main Authors:	Zhong-Chen Li, Jie Wang, He-Bin Liu, Yi-Min Zheng, Jian-Hang Huang, Jia-Bin Cai, Lei Zhang, Xin Liu, Ling Du, Xue-Ting Yang, Xiao-Qiang Chai, Ying-Hua Jiang, Zheng-Gang Ren, Jian Zhou, Jia Fan, De-Cai Yu, Hui-Chuan Sun, Cheng Huang, Feng Liu
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Cell Reports
Subjects:	CP: Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124724002055

Similar Items

PANAMA-enabled high-sensitivity dual nanoflow LC-MS metabolomics and proteomics analysis
by: Weiwei Lin, et al.
Published: (2024-07-01)

PD-1 deficiency impairs eosinophil recruitment to tissue during Trichinella spiralis infection
by: Yiqi Liu, et al.
Published: (2024-11-01)

Hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors versus lenvatinib and PD-1 inhibitors for unresectable HCC: a meta-analysis
by: Min Wei, et al.
Published: (2024-12-01)

HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study
by: Xu Chang, et al.
Published: (2024-04-01)

Periostin deficiency reduces PD-1+ tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer
by: Tian Wei, et al.
Published: (2023-02-01)

T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics
by: Jianhong Liao, et al.
Published: (2024-04-01)

Hyperpolarization-activated cyclic nucleotide-gated cation channel 3 promotes HCC development in a female-biased manner
by: Yueqi Zhang, et al.
Published: (2023-10-01)

Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study
by: Wei‐Jun Wang, et al.
Published: (2023-05-01)

Global and tissue-specific aging effects on murine proteomes
by: Gregory R. Keele, et al.
Published: (2023-07-01)

PD-L1 restrains PD-1+Nrp1lo Treg cells to suppress inflammation-driven colorectal tumorigenesis
by: Dakota B. Poschel, et al.
Published: (2024-10-01)

Extracellular vesicle-packaged PD-L1 impedes macrophage-mediated antibacterial immunity in preexisting malignancy
by: He-Jing Zhang, et al.
Published: (2024-11-01)

PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
by: He Z, et al.
Published: (2025-01-01)

Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapy
by: Qicong Luo, et al.
Published: (2023-05-01)

Simultaneous deep transcriptome and proteome profiling in a single mouse oocyte
by: Yi-Rong Jiang, et al.
Published: (2023-11-01)

Predictors of short- and long-term survival in unresectable hepatocellular carcinoma (uHCC) treated with transcatheter arterial chemoembolization combined with lenvatinib plus PD-1 inhibitors: a multicenter retrospective study
by: Zhen-Xin Zeng, et al.
Published: (2025-02-01)

Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury
by: Yiheng Mao, et al.
Published: (2024-02-01)

Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2
by: Zhen Wu, et al.
Published: (2023-07-01)

Paired microbiome and metabolome analyses associate bile acid changes with colorectal cancer progression
by: Ting Fu, et al.
Published: (2023-08-01)

4-Octyl itaconate restricts STING activation by blocking its palmitoylation
by: Chaofei Su, et al.
Published: (2023-09-01)

Synthetic lethal CRISPR screen identifies a cancer cell-intrinsic role of PD-L1 in regulation of vulnerability to ferroptosis
by: Yang-Ying-Fan Feng, et al.
Published: (2024-07-01)

Integrin subunit beta 8 contributes to lenvatinib resistance in HCC
by: Wei Hou, et al.
Published: (2022-07-01)

A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy
by: William W. Tang, et al.
Published: (2025-02-01)

Comparative spatial proteomics of Plasmodium-infected erythrocytes
by: Anthony Siau, et al.
Published: (2023-11-01)

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
by: Andrea Ziblat, et al.
Published: (2024-05-01)

A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline
by: Luke Reilly, et al.
Published: (2023-10-01)

NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression
by: Wenchao Xu, et al.
Published: (2025-02-01)

Immune pathway activation in neurons triggers neural damage after stroke
by: Dong-mei Wu, et al.
Published: (2023-11-01)

The Idesia polycarpa genome provides insights into its evolution and oil biosynthesis
by: Yi Zuo, et al.
Published: (2024-03-01)

Temporal alterations of the nascent proteome in response to mitochondrial stress
by: Tomasz M. Stępkowski, et al.
Published: (2024-10-01)

scCURE identifies cell types responding to immunotherapy and enables outcome prediction
by: Xin Zou, et al.
Published: (2023-11-01)

A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer
by: Jia-Hao Zheng, et al.
Published: (2024-08-01)

Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination
by: Bin Ju, et al.
Published: (2023-06-01)

Multi-omics reveals immune response and metabolic profiles during high-altitude mountaineering
by: Jianhua Yin, et al.
Published: (2025-01-01)

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
by: Yimin Zheng, et al.
Published: (2023-10-01)

Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis
by: Jiali Dong, et al.
Published: (2024-03-01)

High-throughput identification of calcium-regulated proteins across diverse proteomes
by: Timothy M. Locke, et al.
Published: (2024-11-01)

PD-L1-mediated immune evasion in triple-negative breast cancer is linked to the loss of ZNF652
by: Yuncheng Liu, et al.
Published: (2023-11-01)

PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy
by: Kaimin Xiao, et al.
Published: (2024-11-01)

Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury
by: Ling Leng, et al.
Published: (2022-06-01)

The proteome and transcriptome of stress granules and P bodies during human T lymphocyte activation
by: Nicolas Curdy, et al.
Published: (2023-03-01)